Current dividend yield | 9.0 % |
Dividendenrendite 5 Jahre | 4.25 % |
Dividend Yield 10Y | 1.6 % |
Payout 3Y | 1.62 % |
Year | Dividend | Ex-day & Payday |
Frequency | |
---|---|---|---|---|
Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
2024 |
GBP0.15
GBP0.15
|
Nov 14 2024
Nov 14 2024
Jan 09 2025
Nov 14 24
Jan 09 25 |
Jan 09 2025 |
-
-
|
2024 |
GBP0.15
GBP0.15
|
Aug 15 2024
Aug 15 2024
Oct 10 2024
Aug 15 24
Oct 10 24 |
Oct 10 2024 |
-
-
|
2024 |
GBP0.15
GBP0.15
|
May 16 2024
May 16 2024
Jul 11 2024
May 16 24
Jul 11 24 |
Jul 11 2024 |
-
-
|
2024 |
GBP0.16
GBP0.16
|
Feb 22 2024
Feb 22 2024
Apr 11 2024
Feb 22 24
Apr 11 24 |
Apr 11 2024 |
-
-
|
2023 |
GBP0.14
GBP0.14
|
Nov 16 2023
Nov 16 2023
Jan 11 2024
Nov 16 23
Jan 11 24 |
Jan 11 2024 |
-
-
|
2023 |
GBP0.14
GBP0.14
|
Aug 17 2023
Aug 17 2023
Oct 12 2023
Aug 17 23
Oct 12 23 |
Oct 12 2023 |
-
-
|
2023 |
GBP0.14
GBP0.14
|
May 18 2023
May 18 2023
Jul 13 2023
May 18 23
Jul 13 23 |
Jul 13 2023 |
-
-
|
2023 |
GBP0.1375
GBP0.14
|
Feb 23 2023
Feb 23 2023
Apr 13 2023
Feb 23 23
Apr 13 23 |
Apr 13 2023 |
-
-
|
2022 |
GBP0.1375
GBP0.14
|
Nov 17 2022
Nov 17 2022
Jan 12 2023
Nov 17 22
Jan 12 23 |
Jan 12 2023 |
-
-
|
2022 |
GBP0.1625
GBP0.16
|
Aug 18 2022
Aug 18 2022
Oct 06 2022
Aug 18 22
Oct 06 22 |
Oct 06 2022 |
-
-
|
GlaxoSmithKline most recently paid a dividend of GBP0.15. GlaxoSmithKline paid a Dividend of GBP0.56 Per Share in the financial year 2023. With a stock price of GBP13.47 at Nov 25 2024, the current dividend yield is 4.14% (calculation: GBP0.56 / GBP13.47 = 4.14%). No special dividend was paid.
The average GlaxoSmithKline dividend yield over the last 5 years is 5.53% and the average over the last 10 years is 6.55%.
The payout ratio of GlaxoSmithKline in relation to the last financial year is 45.70%. The payout ratio smoothed over 3 years is 32.18%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
Metric | GlaxoSmithKline |
---|---|
Current dividend yield | 4.14% |
Dividend Yield 5Y | 5.53% |
Dividend Yield 10Y | 6.55% |
Payout 1Y | 45.70% |
Payout 3Y | 32.18% |
GlaxoSmithKline has been paying a dividend for 25 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
The Dividend Growth in relation to the previous financial year amounts to -16.79%. The average GlaxoSmithKline Dividend Growth over the last 5 years is -6.97%. The average for the last 10 years is -4.83%.
Metric | GlaxoSmithKline |
---|---|
Increased | 0 Years |
Continuity | 0 Years |
Paid | 25 Years |
Growth 1Y | -16.79% |
Growth 5Y | -6.97% |
Growth 10Y | -4.83% |
GlaxoSmithKline has been paying a dividend for 25 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
The Dividend Growth in relation to the previous financial year amounts to -16.79%. The average GlaxoSmithKline Dividend Growth over the last 5 years is -6.97%. The average for the last 10 years is -4.83%.
On the stock exchange, the GlaxoSmithKline stock (ISIN: GB00BN7SWP63) is not traded as a top scorer in November 2024 according to the dividend strategy.
The stock price of GlaxoSmithKline -3.51% has fallen since the beginning of the year 2024. However, the return generated in the past says nothing about the future return. You can find the GlaxoSmithKline stock price in real time at the top of the page.
GlaxoSmithKline (symbol: GSK) is valued at a Price / Earnings Ratio (P/E ratio) of 21.83 and a price/sales ratio (P/S ratio) of 1.75 valued. Based on analyst estimates, the GlaxoSmithKline stock forecast 2024 of the current financial year corresponds to a valuation of 13.62 according to P/E ratio and 1.76 according to P/S.
Metric | GlaxoSmithKline |
---|---|
Dividend Score | ??/15 |
Performance 2024 |
3.51%
|
P/E TTM | 21.83 |
P/S TTM | 1.75 |
P/E forward | 13.62 |
P/S forward | 1.76 |
GlaxoSmithKline (symbol: GSK) is valued at a Price / Earnings Ratio (P/E ratio) of 21.83 and a price/sales ratio (P/S ratio) of 1.75 valued. Based on analyst estimates, the GlaxoSmithKline stock forecast 2024 of the current financial year corresponds to a valuation of 13.62 according to P/E ratio and 1.76 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.